Months of Growth: This Glorious Growth Stock Could Soar
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Understanding the value of points versus cash back helps you make smart financial choices. Compare both to see which is more beneficial.
28,391 articlesA stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Active ETFs are reshaping how people think about investing. This article explains what they are, when they can beat p...